Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to roll out on the NHS the Minderoo Precision Brain Tumour Programme (MPBTP) introduced at Addenbrooke’s Hospital, Cambridge to improve care for brain cancer patients.

The Minderoo Precision Brain Tumour Programme has recruited over 100 patients for whole genome sequencing in its first year and has returned results within three weeks of surgery on average. This has led to funding for a United Kingdom precision platform trial in brain cancer, which is anticipated to be available to patients at specific centres in 2023. The deployment dates and locations of these centres will be determined by a separate selection process.